{
  "ticker": "LLY",
  "target_date": "2025-01-30",
  "actual_date": "2025-01-30",
  "collected_at": "2025-12-08T11:20:39.028564",
  "price": {
    "open": 802.42,
    "high": 818.51,
    "low": 799.04,
    "close": 817.1350708007812,
    "volume": 2643000,
    "change_1d_pct": 2.38,
    "change_7d_pct": 10.9,
    "change_30d_pct": 4.32
  },
  "technicals": {
    "rsi_14": 58.26,
    "sma_20": 770.2,
    "sma_50": 773.39,
    "macd": 5.47,
    "macd_signal": -1.891,
    "macd_histogram": 7.361,
    "bb_upper": 821.56,
    "bb_lower": 718.83,
    "price_vs_sma20_pct": 6.09,
    "price_vs_sma50_pct": 5.66,
    "volume_ratio": 0.69
  },
  "fundamentals": {
    "market_cap": 889702842368,
    "pe_ratio": 48.626457,
    "forward_pe": 43.798145,
    "price_to_book": 37.366943,
    "price_to_sales": 14.973171,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.75,
    "pct_from_52w_low": 59.11
  },
  "macro": {
    "spy": {
      "price": 599.78,
      "change_1d_pct": 0.54,
      "change_7d_pct": -0.23
    },
    "vix": {
      "level": 15.84,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.51
    },
    "dollar_index": {
      "level": 107.8
    },
    "gold": {
      "price": 2823.0
    },
    "regime": "BEAR_NORMAL"
  },
  "news": [
    {
      "headline": "Voyager: Crossing The Blood-Brain Barrier, Competitors, And Investment Relevance",
      "source": "SeekingAlpha",
      "datetime": 1738256764,
      "summary": "Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's results. Click for this VYGR update.",
      "url": "https://finnhub.io/api/news?id=df0472f0d9bbaa3ae1653611aab840d47121551d78f2f5f5d1585eec4d644274"
    },
    {
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "source": "MarketWatch",
      "datetime": 1738254660,
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=71c91dac46d903ee3e4c5b67521125103905658ec693ec1fa47a7a1f2bf696c6"
    },
    {
      "headline": "Tectonic Therapeutic: Stock Spikes On Heart Failure Data -- Why I See Further Upside",
      "source": "SeekingAlpha",
      "datetime": 1738248104,
      "summary": "Tectonic Therapeutic, Inc.'s stock surged 120% on positive Phase 1b data for TX45 in treating PH-HFpEF, offering a potential opportunity. Click for more on TECX.",
      "url": "https://finnhub.io/api/news?id=6108b712518250bc0ecbb464c89424085bbce31f9667c8802e26347492f65294"
    },
    {
      "headline": "Scholar Rock: More Than Just An SMA Biotech With Q2 2025 Obesity Treatment Data",
      "source": "SeekingAlpha",
      "datetime": 1738226235,
      "summary": "Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for Priority Review to be given. Explore more details here.",
      "url": "https://finnhub.io/api/news?id=813f714acfa9378c145e3187e1ff78e9146f723c4186b24383fbf135dd9cf133"
    },
    {
      "headline": "Eli Lilly Stock's Correction Brings Opportunity",
      "source": "SeekingAlpha",
      "datetime": 1738157273,
      "summary": "Eli Lilly and Company's correction may be coming to an end as the actual demand for its drugs seems to be holding well. Learn more about LLY stock here.",
      "url": "https://finnhub.io/api/news?id=aa212201579fa1eae1e193e7410ec4c0c10bcb8218ee8f54b6f3b6c66cadc823"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667469.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000016/xslF345X05/wk-form4_1737667469.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667411.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000014/xslF345X05/wk-form4_1737667411.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667361.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000012/xslF345X05/wk-form4_1737667361.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667303.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000010/xslF345X05/wk-form4_1737667303.xml"
    },
    {
      "form": "4",
      "date": "2025-01-23",
      "description": "xslF345X05/wk-form4_1737667237.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000008/xslF345X05/wk-form4_1737667237.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}